Alexandra Savell

Ipilimumab for Patients with Relapse after Allogeneic Transplantation

Matthew S. Davids, Haesook T. Kim, Pavan Bachireddy et al. · New England Journal of Medicine · 2016 · 588 citations · Full text

Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study

Matthew S. Davids, Haesook T. Kim, Alyssa Nicotra et al. · The Lancet Haematology · 2018 · 113 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Mantle Cell Lymphoma +10

A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma

Irene M. Ghobrial, Chia‐Jen Liu, Robert Redd et al. · Clinical Cancer Research · 2019 · 97 citations · Full text

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

Matthew S. Davids, Haesook T. Kim, Caitlin Costello et al. · Blood · 2020 · 97 citations · Full text

Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial

Matthew S. Davids, Danielle M. Brander, Haesook T. Kim et al. · The Lancet Haematology · 2019 · 70 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Chronic Lymphocytic Leukaemia +11